| Patents for C07J 3 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by one carbon atom (1,033) |
|---|
| 02/04/2015 | CN104327144A 3-羟基-5-雄烯-17β羧酸甲酯的制备方法 Preparation 3- hydroxy-5-carboxylate androstenedione -17β |
| 01/15/2015 | US20150018326 Compositions and methods for inhibiting norovirus infection |
| 01/14/2015 | CN104277089A 一种雄甾-17β-羧酸的制备方法 One kind androst -17β- acid preparation |
| 12/17/2014 | CN101585862B 甾族化合物 Steroid |
| 09/23/2014 | CA2637548C Novel 11 beta - hydroxyandrosta-4-ene-3-ones |
| 09/04/2014 | US20140249120 Neuroactive 13, 17-substituted steroids as modulators for gaba type-a receptors |
| 07/22/2014 | US8785425 11β-hydroxyandrosta-4-ene-3-ones |
| 07/01/2014 | US8765725 Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof |
| 06/24/2014 | US8759304 Compositions and methods for increasing telomerase activity |
| 06/19/2014 | US20140171645 Electrophilic alkylating reagents, their preparation and use |
| 05/14/2014 | CN103797022A 桦木酮酸和Boc-赖氨酸化桦木酮酸的提纯方法，以及利用哌嗪衍生物制备桦木酮酸酰胺的有机合成方法 Birch acid and lysine Boc- of birch acid purification methods, and the use of organic synthetic methods for preparing birch acid amide derivative of piperazine |
| 05/07/2014 | CN103781794A 用于生产雄甾烷-17-β-羧酸的氟甲基-酯的方法 For the production of androstane -17-β- acid fluoromethyl - method ester |
| 04/16/2014 | CN103732608A A use of a composition comprising of acylated steryl glucoside in the manufacture of a product |
| 04/16/2014 | CN101974052B Method for synthesizing androstane-3-ketone-4-alkene-17beta carboxylic acid |
| 04/09/2014 | EP2714711A1 Method for the production of fluoromethyl - esters of androstan- 17 - beta - carboxylic acids |
| 03/26/2014 | EP2710022A2 A use of a composition comprising of acylated steryl glucoside in the manufacture of a product |
| 02/13/2014 | US20140046061 Processes Employing Cyclodextrin Derivative Quaternary Salts |
| 11/19/2013 | US8586770 Unsaturated steroid compounds |
| 11/14/2013 | US20130303502 Preparations of Hydrophobic Therapeutic Agents, Methods of Manufacture and Use Thereof |
| 10/17/2013 | US20130274460 Electrophilic Reagents for Monohalomethylation, Their Preparation and Their Uses |
| 08/14/2013 | CN101654470B Intermediate used as anti-inflammatory androstane derivative compositions and uses thereof |
| 08/08/2013 | US20130203718 Progesterone receptor antagonists and uses thereof |
| 07/23/2013 | US8492570 2-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumor action |
| 07/17/2013 | CN101384610B Novel 11 beta - hydroxyandrosta-4-ene-3-ones |
| 07/10/2013 | CN103193844A Method for synthesizing key intermediate of fluticasone propionate |
| 07/04/2013 | US20130172587 Process for the Preparation of Fluticasone Propionate |
| 07/03/2013 | CN103183714A Synthetic method for loteprednol |
| 06/13/2013 | WO2013002592A3 Method for purifying high-purity betulonic acid, method for preparing piperazine betulonic acid amide derivative using high-purity betulonic acid and derivative thereof, and method for purifying high-purity boc-lysinated betulonic acid using high-purity betulonic acid |
| 05/01/2013 | CN103073609A Synthesis method of key intermediate 17-beta-carboxylic acid derivative of fluticasone derivative |
| 04/25/2013 | WO2012161559A3 A use of a composition comprising of acylated steryl glucoside in the manufacture of a product |
| 03/21/2013 | US20130072698 Method and Compounds for the Preparation of Monofluoromethylated Biologically Active Organic Compounds |
| 02/06/2013 | CN102911231A Synthetic method of loteprednol immediate |
| 02/06/2013 | CN101942001B Purification method of loteprednol etabonate |
| 01/16/2013 | CN102180928B 3-beta,5-alpha,6-beta-trihydroxy steroid compounds, and synthesis method and application thereof |
| 01/09/2013 | CN101759741B Compound and application thereof in preparation of medicine for treating angiogenesis |
| 01/08/2013 | US8349819 Steroid extraction process from urine sources |
| 01/01/2013 | US8344168 Process for the preparation of fluticasone propionate |
| 11/29/2012 | WO2012161559A2 A use of a composition comprising of acylated steryl glucoside in the manufacture of a product |
| 11/29/2012 | WO2012160338A1 Method for the production of fluoromethyl - esters of androstan- 17 - beta - carboxylic acids |
| 11/28/2012 | CN102802634A 17[beta]-alkyl-17[alpha]-oxy-estratrienes |
| 10/24/2012 | CN101775055B Method for synthesizing 4-trifluoromethyl-4-olefine-3-steroidal ketone compound |
| 09/19/2012 | CN101479291B Amino derivatives of B-homoandrostanes and B-heteroandrostanes |
| 08/23/2012 | US20120214987 Methods and compounds for preparing 3alpha-oxygen substituted steroids |
| 07/26/2012 | WO2012099477A1 Biosurface engineering |
| 07/04/2012 | CN101659688B Method for recrystallizing and refining fluticasone propionate |
| 06/26/2012 | US8207150 17β-cyano-19-nor-androst-4-ene derivative, its use and medicaments comprising the derivative |
| 06/21/2012 | US20120157421 17Beta-Alkyl-17Alpha-oxy-estratrienes |
| 06/07/2012 | US20120142651 Method of treatment of allergic rhinitis |
| 05/22/2012 | US8183402 Industrial method for the synthesis of 17-acetoxy-11β[4-(dimethylamino)-phenyl]-21-methoxy-19-norpregna-4,9-dien-3,20-dione and the key intermediates of the process |
| 05/09/2012 | CN102448978A Novel Glucocorticoid Receptor Agonists |
| 05/08/2012 | CA2531905C Specific glucocorticosteroid compound having anti-inflammatory activity |
| 04/11/2012 | EP2437746A2 17 beta-alkyl-17 alpha-oxy-estratrienes |
| 04/04/2012 | EP2435462A1 Novel glucocorticoid receptor agonists |
| 03/14/2012 | CN102372756A Specific glucocorticosteroid compound having anti-inflammatory activity |
| 02/16/2012 | US20120040945 Use of a Glucocorticoid Composition for the Treatment of Severe and Uncontrolled Asthma |
| 01/31/2012 | US8106036 Pharmaceutical compositions-4 |
| 01/26/2012 | WO2012011106A1 Process for the preparation of 17-desoxy-corticosteroids |
| 01/10/2012 | CA2492079C Microbiological processes for the production of 7 alpha-substituted 11 alpha-hydroxy steroids |
| 12/20/2011 | CA2733294C Pharmaceutical combination of a tiotropium salt and ciclesonide |
| 11/01/2011 | CA2531911C Specific glucocorticosteroid having an anti-inflammatory activity |
| 10/26/2011 | EP2380898A1 Process to make glucocortisoid compounds |
| 10/20/2011 | US20110257142 Method for preparing 4-[17beta-methoxy-17alpha-methoxymethyl-3-oxoestra-4,9-dien-11-beta-yl]benzaldehyde (e)-oxime (asoprisnil) |
| 10/05/2011 | CN1845933B Specific glucocorticosteriod compound having anti-inflamatory activity |
| 09/14/2011 | CN102180928A 3-beta,5-alpha,6-beta-trihydroxy steroid compounds, and synthesis method and application thereof |
| 09/07/2011 | EP2363121A1 Pharmaceutical formulation for administration by inhalation comprising an androstane derivative and a beta-2-adrenoreceptor agonist for the treatment of inflammatory and allergic conditions |
| 09/07/2011 | CN102175750A Method for analyzing biological samples by using matrix assisted laser desorption ionization-Fourier transform ion cyclotron resonance mass spectra |
| 09/06/2011 | US8012952 Cationic 17 α-substituted-estradiol derivatives useful as anti-cancer agent |
| 08/23/2011 | CA2478186C Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 07/27/2011 | EP2348030A2 17-Alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents |
| 07/27/2011 | EP1841780B1 Androstane 17-alpha-carbonate derivatives for use in the treatment of allergic and inflammatory conditions |
| 06/23/2011 | US20110146678 Process for improving crystallinity |
| 06/16/2011 | US20110144071 Crystalline active ingredient microparticles, method for producing the same and use thereof in drugs |
| 05/25/2011 | CN1849330B Specific glucocorticosteroid compound having anti-inflammatory activity |
| 05/18/2011 | EP2322182A1 Androstenol derivatives as androgen receptor modulator |
| 05/03/2011 | US7935839 Sepsis treatment methods |
| 05/03/2011 | US7935837 Process for synthesis of androstane 17-β carbothioic acid and relative compounds thereof |
| 04/07/2011 | US20110081411 Orally Administered Corticosteroid Compositions |
| 03/10/2011 | WO2010139411A3 17β-ALKYL-17α-OXY-ESTRATRIENES |
| 02/22/2011 | US7893284 Oestrogen derivatives as inhibitors of steroid sulphatase |
| 02/16/2011 | CN101974052A Method for synthesizing androstane-3-ketone-4-alkene-17beta carboxylic acid |
| 02/02/2011 | EP2032593B1 Amino derivatives of b-homoandrostanes and b-heteroandrostanes |
| 01/20/2011 | US20110014641 Method for measuring aromatase activity |
| 01/12/2011 | CN101942001A Purification method of loteprednol etabonate |
| 12/09/2010 | US20100311706 Method of treatment of allergic rhinitis |
| 12/09/2010 | CA2764249A1 17.beta.-alkyl-17.alpha.-oxy-oestratrienes |
| 12/08/2010 | EP2258375A1 17B-alkyl-17alpha-oxy-estratrienes |
| 12/02/2010 | WO2010136940A1 Novel glucocorticoid receptor agonists |
| 12/02/2010 | US20100303758 Novel Glucocorticoid Receptor Agonists |
| 12/02/2010 | CA2760284A1 Novel glucocorticoid receptor agonists |
| 10/14/2010 | US20100261917 Process for producing vitamin d derivative using photoreaction |
| 10/07/2010 | US20100255117 Methods and compositions for the treatment of cancer |
| 09/02/2010 | US20100222313 Pharmaceutical compositions-4 |
| 08/11/2010 | CN101798331A Process for preparing fluticasone diproprionate superfine particles and product thereof |
| 07/27/2010 | US7763596 Antiinflamamtory agents; immunosuppressants; antiproliferative agents; treating haematology; reduced harmful side-effects |
| 07/27/2010 | CA2427569C Selective glucocorticoid receptor agonists |
| 07/14/2010 | CN101775055A Method for synthesizing 4-trifluoromethyl-4-olefine-3-steroidal ketone compound |
| 07/01/2010 | WO2009108388A8 Enzymatic production or chemical synthesis and uses for 5,7-dienes and uvb conversion products thereof |
| 06/30/2010 | CN101759741A Compound and application thereof in preparation of medicine for treating angiogenesis |
| 06/24/2010 | WO2010071772A2 Synthesis of 3b-amino-5-cholestene and related 3b-halides involving i-steroid and retro-i-steroid rearrangements |
| 06/24/2010 | US20100160657 Synthetic mimics of mammalian cell surface receptors: method and compositions |